AstraZeneca
rare disease | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
November 2021
Slide
32 of 39
Related slides by other companies
Aeglea BioTherapeutics
Investor Presentation
July 2023
inflammatory bowel disease is a growing market in which are the preferred modality | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
July 2023
inflammatory bowel disease is a growing market in which are the preferred modality | Aeglea BioTherapeutics
Ocuphire Pharma
Results
October 2022
global prevalence of diabetes associated retinal disease arn | Ocuphire Pharma
Aeglea BioTherapeutics
Mergers and Acquisitions
June 2023
inflammatory bowel disease is a growing market in which are the preferred modality as | Aeglea BioTherapeutics
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights